Tamiram

Quick links to important sections

Tamiram

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tamiram

Property Description
Active Ingredient Levofloxacin
Forms Coated Tablets, Intravenous Solution
Pharmacological Class Fluoroquinolone Antibiotic
General Purpose Management of Bacterial Infections
Origin Synthetic Compound

What Type of Medication is Tamiram?

Tamiram is the recognized brand name for the medicine containing the active ingredient Levofloxacin. It is classified as an antibiotic and belongs to the powerful fluoroquinolone pharmacological class. Levofloxacin is a purely synthetic compound, specifically the active S-enantiomer of Ofloxacin, which possesses an enhanced activity profile against various pathogens. The medication is generally designated as a prescription-only drug, signifying its professional-grade use in medicine.

Composition and Pharmaceutical Form

The medicine is a single-entity drug, meaning its full therapeutic action is provided solely by the active ingredient, Levofloxacin. The product is made available in multiple presentations to suit clinical needs, chiefly as coated tablets for convenient oral administration and a sterile solution for intravenous infusion for hospital-based care. This dual-route availability facilitates the transition of patients from intravenous therapy in a hospital setting to oral therapy upon discharge, a process known as sequential therapy.

General Purpose: What Does Levofloxacin Do?

The general purpose of this medication is to help the body effectively stop and eliminate established bacterial infections. Levofloxacin achieves this through a bactericidal effect, which means it actively and rapidly kills the targeted bacteria rather than just slowing their growth. Levofloxacin possesses a broad-spectrum capability, allowing it to combat a wide range of susceptible pathogens. Its mechanism involves interrupting the bacteria’s vital genetic processes, which leads to the eradication of the infecting organisms.

What side effects are possible with Tamiram?

Possible Side Effects and Safety Information

The safety profile of Tamiram (Levofloxacin) is formally documented by regulatory authorities, classifying possible adverse reactions by frequency and the physiological system affected.

Adverse effects are categorized by frequency, based on official regulatory standards, including Common (such as headache, insomnia, nausea, and diarrhea) and Uncommon (including anxiety, tremor, and rash).

System-Organ Class Common Adverse Reactions
Gastrointestinal Nausea, Diarrhea, Constipation
Nervous System Headache, Dizziness, Insomnia
Psychiatric Insomnia

Official labeling highlights the potential for serious adverse reactions that can be disabling and potentially irreversible. These include effects on the Musculoskeletal and Nervous System, such as Tendon Rupture (tendinopathy) and Peripheral Neuropathy (nerve damage) which may occur during or up to several months after treatment completion. Other serious concerns documented in regulatory warnings are Aortic Aneurysm and Dissection, severe Hypoglycemia (low blood sugar), and potentially life-threatening Hypersensitivity reactions.

Population-specific safety considerations are noted in the official prescribing information. Older adults are identified as having a greater risk for tendon disorders and QTc prolongation. Similarly, patients with diabetes mellitus face an increased risk of severe blood glucose disturbances. Regulatory restrictions also contraindicate use in individuals with a history of tendon disorders related to fluoroquinolone administration.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Tamiram (azithromycin) can lead to exaggerated adverse reactions, which are generally similar to those seen at normal therapeutic doses. Official regulatory documents indicate that the most common symptoms following the ingestion of doses higher than recommended include severe nausea, vomiting, and diarrhea.

However, a severe overdose carries a risk of more serious, potentially life-threatening complications related to the cardiovascular and auditory systems.

System Documented Overdose Manifestations
Gastrointestinal Severe nausea, vomiting, diarrhea
Cardiovascular Cardiac arrhythmias (e.g., ventricular tachycardia), QT interval prolongation
Auditory Reversible hearing loss

In the event of a known or suspected overdose, immediate medical attention is required because of the potential for serious cardiac effects. Management of an overdose is primarily supportive and symptomatic. Regulatory guidance for healthcare professionals emphasizes that necessary steps include gastric lavage to help remove any unabsorbed drug and monitoring of cardiac function, typically with an electrocardiogram (ECG/EKG).

If an overdose is suspected, the drug should be stopped immediately. Contact a Poison Control Center or emergency medical services without delay, even if symptoms are not immediately present or appear mild.

Therapeutic Uses of Tamiram

Tamiram (Levofloxacin) is a broad-spectrum antibiotic used in the management of bacterial infections and provides supportive relief that helps ease the overall symptom burden. It is commonly applied when bacterial pathogens cause significant, disruptive illness across several key systems. The medication is utilized to address a wide array of specific bacterial conditions.

This medication is relevant across domains where additional symptomatic support is needed, primarily addressing conditions such as community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis, complicated and uncomplicated urinary tract infections, acute pyelonephritis, complicated skin and skin structure infections, and chronic bacterial prostatitis. It may assist with easing severe localized pain, burning discomfort, and systemic manifestations like fever and chills, aiming to address symptoms related to systemic imbalance.

“It is commonly used across conditions presenting with acute episodes, where managing symptoms related to organ-specific functional stress is appropriate.”

Quick Fact: Relief for Acute Discomfort

Tamiram supports patients during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable. It is applied in clinical settings that involve acute or unstable symptom patterns, contributing to improved day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use Tamiram (Levofloxacin)

The official eligibility profile for Tamiram, a fluoroquinolone antibiotic, strictly defines who can and cannot use the medicine based on regulatory labeling.

Absolute Contraindications

Tamiram is contraindicated in several patient groups, meaning they must not use the medicine. These include individuals with a known hypersensitivity to levofloxacin or to any other quinolone antibacterial agent. It is also prohibited for patients with a history of tendon disorders related to previous fluoroquinolone use, and for those with epilepsy. Furthermore, use is contraindicated in children or growing adolescents for general treatment, and during pregnancy and breastfeeding.

Populations Requiring Restrictions

Use of the medicine is restricted or requires caution in other specific populations. It should be avoided in patients with a history of myasthenia gravis and those with known prolongation of the QT interval or hypokalemia. Patients with renal impairment (Creatinine Clearance leq 50 mL/min) require official dose adjustment to maintain safe use. Use in older adults carries an increased risk of tendon disorders, and co-administration with corticosteroids is generally avoided due to heightened risk of tendon rupture. Adults (age 18 and older) are the primary approved user population.

What should I know about interactions with other medicines?

Officially documented interactions for Levofloxacin (Tamiram) involve several product categories, including multivalent cation-containing products, Warfarin, antidiabetic agents, corticosteroids, and QT-prolonging drugs.

Pharmacokinetic and Timing Constraints

The primary mechanistic basis for one documented interaction is chelation, which causes decreased absorption of the oral medicine when co-administered with multivalent cation-containing products (such as antacids or multivitamins with minerals). The regulatory label mandates a timing separation of at least two hours between the oral tablet and these substances. The intravenous formulation must not be co-administered in the same IV line with any multivalent cation. Furthermore, co-administration with Probenecid or Cimetidine reduces Levofloxacin's renal clearance, which increases systemic exposure.

Pharmacodynamic and Risk Profile

Levofloxacin carries an additive toxicity risk with specific co-administered medications. Concomitant use with corticosteroids is officially associated with an increased risk of tendinopathy and tendon rupture, a risk that is explicitly noted as heightened in geriatric patients. Use with other QT-prolonging drugs increases the documented risk of QT interval prolongation. The effect of Warfarin may be enhanced by Levofloxacin, necessitating the formal monitoring of clotting metrics by a healthcare provider, as documented in the prescribing information.

Mechanism of Action

Disruption of Bacterial DNA Synthesis

Levofloxacin, the active component of Tamiram, functions as a rapid inhibitor of two essential bacterial enzymes, DNA Gyrase (Topoisomerase II) and Topoisomerase IV. By binding to and stabilizing the enzyme-DNA cleavage complex, the compound specifically prevents the critical re-ligation of the bacterial DNA strands. This interaction disrupts the bacteria's entire genetic process—replication, repair, and chromosome segregation—leading directly to a state of irreversible molecular damage.

Initiation of the Bactericidal Cascade

This molecular interference initiates a destructive, bactericidal cascade resulting in the accumulation of lethal double-stranded DNA breaks within the bacterial cell. This mechanism drives the swift and concentration-dependent elimination of susceptible pathogens, which is the foundational physiological change resulting from the clearance of viable pathogens.

️ Constraints by Bacterial Resistance

The mechanism's effectiveness at the bacterial level is biologically limited by bacterial resistance, primarily through genetic mutations in the target enzymes that reduce drug binding, or the active expulsion of the drug from the cell via efflux pumps. These constraints prevent Levofloxacin from reaching the necessary intracellular concentration or affinity to fully execute the lethal DNA-breaking mechanism.

Dosage and Administration Information

How to Use Tamiram: Administration Guidelines

Tamiram, which contains the antibiotic Levofloxacin, is administered through two primary approved routes: oral (using coated tablets or oral solution) and intravenous (IV) infusion. This dual availability supports sequential therapy, allowing a patient to transition from hospital-based IV treatment to oral use when clinically appropriate.

The standard dosing frequency for nearly all approved regimens is once daily (every 24 hours). Adult doses typically fall within 250 mg, 500 mg, or 750 mg per dose, with the course duration ranging significantly from 3 days up to 60 days, depending on the specific use pattern. Oral tablets may be taken with or without food.

Key procedural instructions are necessary for proper use. Oral forms must be consumed at least two hours apart from products containing multivalent cations, such as antacids or iron supplements, to prevent poor absorption. When administered intravenously, the solution must be given by slow infusion, taking a minimum of 60 minutes for 250 mg and 500 mg doses, or 90 minutes for the 750 mg dose; rapid injection is forbidden.

Dosing requires modification for certain patient populations. For adults with impaired renal function (creatinine clearance leq 50 mL/min), a dose reduction or adjusted frequency is necessary to prevent accumulation. Pediatric use is generally restricted to specific severe infections, requiring precise weight-based dosing.

Recent Clinical Evidence

Research evidence / Overview of studies for Tamiram

Evidence for Use in Acute Infections

Tamiram (Levofloxacin) was studied for the management of acute infections, including Community-Acquired Pneumonia (CAP) and Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). The evidence base includes Randomized Controlled Trials (RCTs) that examined outcomes related to systemic imbalance, focusing on how symptoms change over time and the microbiological eradication rate of the causative bacteria. For these conditions, findings describe patterns observed in studies related to measurements of symptom change and bacterial status, typically tracked in the short-term. Regulatory documents note that evidence may support its application in specific situations where other treatment options may not be appropriate.


Evidence for Use in Urinary Tract and Chronic Infections

Levofloxacin was studied for Complicated Urinary Tract Infections (cUTI) and Chronic Bacterial Prostatitis (CBP). For cUTI, research monitored clinical success rates (symptom resolution) and the rate of bacterial clearance in short-term follow-up. For CBP, studies were observed in adult males over a more extended period, with trials examining patient-reported outcomes describing discomfort and microbiological eradication at time points up to six months post-treatment. This extended follow-up was evaluated to assess whether the microbiological status was associated with patient-reported symptom patterns.


Evidence Gaps and Areas of Uncertainty

Research highlights several areas where certainty remains low. Follow-up durations were limited for many acute conditions, meaning long-term changes and effects are not well characterized. Evidence quality varies across studies, and subgroup findings are uncertain for patients with multiple complex underlying health conditions. Furthermore, regulatory bodies have noted a research gap regarding the relationship between the use of the drug and the development of long-term bacterial resistance patterns.

Key Studies & References

  1. Levofloxacin - StatPearls - NCBI Bookshelf (NIH)
  2. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis (CBP Follow-up Study)

Frequently Asked Questions (FAQ)

Common questions about Tamiram (FAQ)

Q: What is the main condition Tamiram is used to treat?

Official labeling states that Tamiram is indicated for managing a range of bacterial infections. These include specific types of Pneumonia (both hospital- and community-acquired), Skin and Skin Structure Infections, Chronic Bacterial Prostatitis, and Urinary Tract Infections. This information is based on the official product indications.


Q: Does Tamiram have an official Black Box Warning in the US?

Yes, the official prescribing information in the US includes a Boxed Warning, which is the most serious safety warning issued by the FDA. This warning alerts users to the risk of serious, potentially disabling, and sometimes irreversible adverse reactions. These reactions can affect the tendons (tendinitis and tendon rupture), nerves (peripheral neuropathy), and the central nervous system.


Q: What is the difference between Tamiram and other similar medicines?

Tamiram is the brand name for the active ingredient Levofloxacin, which is part of the fluoroquinolone class of antibiotics. Regulatory documents classify it this way because its mechanism of action is distinct: it works by disrupting the vital genetic processes of bacteria. This helps to explain the specific range of bacteria it is effective against.


Q: Is Tamiram safe for older adults (geriatric patients)?

Official prescribing information notes that older adults (geriatric patients) are identified as having an increased risk for certain serious adverse reactions. These include a higher potential for tendon disorders and QTc prolongation (an effect on heart rhythm). Regulatory information notes that increased caution is generally applied when this medicine is used in the older adult population.


Q: Can Tamiram affect my ability to drive or operate machinery?

Official patient counseling information indicates that this medicine may cause side effects such as dizziness or lightheadedness. Due to the potential for these effects, caution should be exercised regarding activities that require alertness, such such as driving or operating heavy machinery.


Q: Is there a list of ingredients in Tamiram besides the main active component?

Yes, official regulatory documents list all components of the medication. The active ingredient is Levofloxacin, and the list of inactive ingredients (excipients) typically includes compounds like hypromellose, crospovidone, microcrystalline cellulose, magnesium stearate, and titanium dioxide.


Q: What happens if I miss a dose of Tamiram?

Official product instructions provide direction for managing a missed dose. These guidelines state that if a dose is forgotten, it is managed by either taking it as soon as it is remembered, or by skipping it if the next scheduled dose is nearly due. The instructions emphasize that two doses should not be taken at once.


Q: Are there any known interactions between Tamiram and caffeine?

Some regulatory-derived information suggests that Levofloxacin can increase the effects of caffeine (and other substances like theophylline) in the body. This interaction may potentially lead to more pronounced central nervous system (CNS) effects.


Q: Does Tamiram affect birth control pills?

Information based on regulatory sources suggests that Levofloxacin may reduce the effectiveness of ethinyl estradiol, which is a hormonal component found in some oral contraceptives. This could potentially increase the risk for pregnancy.


Q: Can Tamiram cause light sensitivity or sunburn?

Official patient safety information notes that this medicine can cause photosensitivity (making the skin very sensitive to the sun). Due to this potential effect, sun exposure is typically restricted, and protective measures are suggested in patient information materials.


Q: Why is Tamiram sometimes used for skin infections?

The medicine is officially indicated for the management of Complicated and Uncomplicated Skin and Skin Structure Infections (SSSI). This is because the active ingredient, Levofloxacin, is effective against the specific range of bacteria that are known to cause these types of skin infections.


Q: Does Tamiram interact with alcohol consumption?

Patient education materials based on official warnings note that alcohol may worsen certain nervous system side effects of the medicine, such as dizziness and mental confusion. For this reason, official guidance suggests avoiding alcohol while taking this medicine.


Q: How long does Tamiram stay in your system after you stop taking it?

Pharmacokinetic studies—which describe how the body processes the drug—indicate that the elimination half-life of the active ingredient is typically between 6 and 12 hours in adults with normal kidney function. This is the time it takes for the concentration of the medicine in the body to be reduced by half.


Q: Do regulatory bodies like the FDA or EMA have specific warnings about Tamiram?

Yes, regulatory bodies issue specific alerts. The FDA requires a Boxed Warning to notify users of the risks of serious, potentially irreversible effects on the tendons, nerves, and central nervous system. These official warnings provide important safety information.


Q: Is there a generic version of Tamiram available?

Yes, Tamiram is a brand name. The active pharmaceutical ingredient is Levofloxacin, which is confirmed by regulatory product listings to be widely available as a generic drug from various manufacturers.


Q: How soon after starting Tamiram should I contact a healthcare provider if I notice a side effect?

Official safety warnings indicate that serious adverse reactions, such as tendon rupture and nerve damage, can occur during treatment or up to several months after treatment completion. The guidance for these events includes immediately discontinuing the use of the medicine.


Q: Are there different brand names for the same active ingredient as Tamiram?

Yes, the active ingredient Levofloxacin is marketed under numerous brand names worldwide. For example, it was historically marketed in the US under the brand name Levaquin, in addition to other names confirmed in regulatory listings.


Q: Does taking Tamiram require any special monitoring or blood tests?

Official documents recommend specific monitoring depending on the patient's existing health conditions. This includes monitoring renal function (kidney health) for patients with kidney impairment and close monitoring of blood glucose levels for diabetic patients. Additionally, clotting metrics are monitored if the medicine is taken with Warfarin.


Q: What is the definition of Tamiram’s primary safety classification?

According to the FDA-approved prescribing information, the active ingredient Levofloxacin is assigned a Pregnancy Category C. This classification is based on animal studies showing an adverse effect on the fetus, although there are no adequate or well-controlled studies in pregnant women.


Q: If a patient is allergic to penicillin, can they safely take Tamiram?

The official contraindications for the medicine specify that it should not be used in patients with a known hypersensitivity to Levofloxacin or to any other drug belonging to the quinolone class of antibiotics. Regulatory sources focus on the quinolone class as the primary safety concern.


Q: What kind of severe skin reactions are associated with Tamiram?

Official documents specifically note the potential for rare but severe and potentially life-threatening allergic skin reactions. These reactions, which are classified as medical emergencies, include Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).


Q: Can Tamiram cause temporary or permanent changes to vision?

Official adverse event reporting includes the potential for vision changes such as decreased vision and photophobia (increased sensitivity to light). Furthermore, the serious adverse reaction of peripheral neuropathy (nerve damage) is noted as potentially permanent, which can sometimes involve ocular or visual symptoms.


Q: Does Tamiram lose effectiveness over time?

The long-term effectiveness of antibiotics is medically limited by the potential for bacterial resistance to develop during or after treatment. Effectiveness is also dependent on the medicine maintaining its stability, which requires the drug to be stored according to required controlled temperature and environmental conditions.

How should Tamiram be stored and disposed of?

Storage and Environmental Requirements

Official labeling for Levofloxacin, the active ingredient in Tamiram, requires specific handling to maintain its stability and effectiveness.

Dosage Form Required Storage Temperature Environmental Protection
Tablets / Oral Solution Controlled Room Temperature: 20 C to 25 C (68 F to 77 F) Store away from moisture and excessive heat
Injection (Premixed) Controlled Room Temperature OR Refrigerated: 2 C to 8 C (36 F to 46 F) Protect from light; avoid excessive heat and freezing

All forms must be kept in a closed container, and freezing the medication is strictly prohibited. The medication must be kept out of the sight and reach of children as a mandated safety precaution.

Official Disposal Rules

Outdated or unused medicine must not be kept. Disposal must align with national, state, and local environmental regulations. Patients are instructed to consult a healthcare professional regarding the proper disposal method for any unused product, which often includes utilizing drug take-back programs or following FDA-recommended at-home disposal steps, rather than discarding in household trash or flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tamiram found in:

A-Z Index: